Back

One-year outcomes after atrial fibrillation ablation with the novel lattice-tip catheter

30 March 2025 (08:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Poster session 1: atrial tachyarrhythmias Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Ilaria My

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)

156 More presentations in this session

Presentation thumbnail
Native left atrial tachycardias clinical and electrophysiological characteristics: insights from a national survey.
Doctor S. Bun (Nice, FR)
Abstract
Presentation thumbnail
A novel immersive catheter ablation simulator based on individualized 3D MR patients' heart models improves ablation performance of future electrophysiologists.
Ms N. Bacha (Lausanne, CH)
Abstract Slides
Presentation thumbnail
Safety and feasibility of same day discharge catheter ablation: initial German experience
Doctor S. Popescu (Luebeck, DE)
Abstract
Presentation thumbnail
Safety, obstetric and neonatal data trend of novel arrhythmia management in pregnant: zero-fluoroscopy catheter ablation vs. antiarrhythmic drugs
Doctor Z. Suleymen (Astana, KZ)
Abstract Slides Video
Presentation thumbnail
Sensor-enabled 3D electroanatomical model optimization in in-vivo porcine and benchtop models
Mr G. Wenzel (Minneapolis, US)
Abstract Slides

Access the full session

Session thumbnail
Poster session 1: atrial tachyarrhythmias

The Event

Event poster

EHRA 2025

30 March 2025 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Pulsed-field ablation using a lattice-tip catheter without general anesthesia is feasible for atrial fibrillation ablation
thumbnail
Congress Presentation
One-year follow-up of patients with persistent atrial fibrillation after Farapulse ablation - comparison of two ablation strategies
thumbnail
Congress Presentation
Pulsed-field ablation using a circular multielectrode catheter for persistent atrial fibrillation: procedural outcomes and lesion durability

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources